Key result
In patients with normal ejection fraction, an AI-enabled ECG prediction of increased left ventricular end-diastolic diameter was associated with a 2.34-fold higher risk of developing new-onset LV dysfunction.
Why the study?
Early identification of patients at high risk of heart failure is important but challenging, and increased left ventricular end-diastolic diameter is an independent risk factor for heart failure and adverse cardiovascular outcomes.
Does an AI-enabled ECG model accurately predict left ventricular diameter and identify patients at risk for future cardiovascular outcomes?
Cohort (n=87,575)
Yes
Does an AI-enabled ECG model accurately predict left ventricular diameter and identify patients at risk for future cardiovascular outcomes?
Answers are grounded in this paper and cite their sources.
An AI-enabled ECG model can accurately predict left ventricular diameter and identify patients with normal ejection fraction who are at high risk for future left ventricular dysfunction and cardiovascular events.
Background Heart failure (HF) is a global disease with increasing prevalence in an aging society. However, the survival rate is poor despite the patient receiving standard treatment. Early identification of patients with a high risk of HF is important but challenging. Left ventricular end-diastolic diameter (LV-D) increase was an independent risk factor of HF and adverse cardiovascular (CV) outcomes. In this study, we aimed to develop an artificial intelligence (AI) enabled electrocardiogram (ECG) system to detect LV-D increase early. Objective We developed a deep learning model (DLM) to predict left ventricular end-diastolic and end-systolic diameter (LV-D and LV-S) with internal and external validations and investigated the relationship between ECG-LV-D and echocardiographic LV-D and explored the contributions of ECG-LV-D on future CV outcomes. Methods Electrocardiograms and corresponding echocardiography data within 7 days were collected and paired for DLM training with 99,692 ECGs in the development set and 20,197 ECGs in the tuning set. The other 7,551 and 11,644 ECGs were collected from two different hospitals to validate the DLM performance in internal and external validation sets. We analyzed the association and prediction ability of ECG-LVD for CV outcomes, including left ventricular (LV) dysfunction, CV mortality, acute myocardial infarction (AMI), and coronary artery disease (CAD). Results The mean absolute errors (MAE) of ECG-LV-D were 5.25/5.29, and the area under the receiver operating characteristic (ROC) curves (AUCs) were 0.8297/0.8072 and 0.9295/0.9148 for the detection of mild (56 ≦ LV-D < 65 mm) and severe (LV-D ≧ 65 mm) LV-D dilation in internal/external validation sets, respectively. Patients with normal ejection fraction (EF) who were identified as high ECHO-LV-D had the higher hazard ratios (HRs) of developing new onset LV dysfunction [HR: 2.34, 95% conference interval (CI): 1.78–3.08], CV mortality (HR 2.30, 95% CI 1.05–5.05), new-onset AMI (HR 2.12, 95% CI 1.36–3.29), and CAD (HR 1.59, 95% CI 1.26–2.00) in the internal validation set. In addition, the ECG-LV-D presents a 1.88-fold risk (95% CI 1.47–2.39) on new-onset LV dysfunction in the external validation set. Conclusion The ECG-LV-D not only identifies high-risk patients with normal EF but also serves as an independent risk factor of long-term CV outcomes.
No takes yet. Share an insight, caveat, or question.
Chen et al. (2022) conducted a cohort in Normal Ejection Fraction (n=87,575). AI-enabled ECG predicted left ventricular end-diastolic diameter (ECG-LV-D) increase vs. Normal ECG-LV-D was evaluated on New-onset LV dysfunction (ECHO-EF ≤ 35%) (HR 2.34, 95% CI 1.78-3.08). In patients with normal ejection fraction, an AI-enabled ECG prediction of increased left ventricular end-diastolic diameter was associated with a 2.34-fold higher risk of developing new-onset LV dysfunction.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: